Azithromycin Intravenous Suppliers & Bulk Manufacturers
Available Forms: Intravenous (IV)
Available Strengths: 500 mg/250 mL, 1000 mg/250 mL
Reference Brands: Zithromax, Z-Pak(US); Zidimax(EU), Aziwok IV (India)
Category:
Antibiotics
Azithromycin IV inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, halting peptide chain elongation. It provides rapid, broad-spectrum activity against respiratory and skin infections, with excellent tissue penetration. Benefits include quick bacterial eradication, usefulness in severe infections, and a favorable safety profile when administered properly.
Azithromycin Intravenous is available in Intravenous (IV)
and strengths such as 500 mg/250 mL, 1000 mg/250 mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Azithromycin Intravenous is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Azithromycin Intravenous can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Azithromycin IV is approved in the EU and US for severe bacterial infections, including respiratory and skin infections. In the EU, brands like Zithromax are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval relies on extensive clinical data; generic options are available. Both regions require detailed dossiers, clinical trial results, manufacturing quality, and pharmacovigilance plans for approval and safety monitoring. Due to its broad-spectrum activity and excellent tissue penetration, strict prescribing and monitoring guidelines are enforced. For regulatory support, dossier preparation, and compliance services, visit PharmaTradz. We ensure seamless market access adhering to European and US standards for safe, effective therapy.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing